Researchers Develop Method for Creating Knockout Cardiac Muscle Cell Lines Using Integrase-Deficient Lentivirus

Researchers have developed a method to create knockout cardiac muscle cell lines using integrase-deficient lentivirus-mediated CRISPR/Cas9 gene editing. This approach allows scientists to study cardiac muscle function and pathology in greater detail, providing a new tool for understanding heart-related diseases. The use of CRISPR/Cas9 technology in this context represents an advancement in genetic engineering, offering precise modifications to target specific genes within cardiac cells.

The study employs integrase-deficient lentivirus as a delivery system for the CRISPR/Cas9 components, ensuring efficient gene editing while minimizing potential integration into the host genome. This technique enables researchers to generate stable knockout cell lines that can be used to investigate the molecular mechanisms underlying cardiac muscle behavior and disease progression. The findings aim to contribute valuable insights into cardiovascular research and may support future therapeutic developments targeting heart conditions.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: November 27, 2025

Related posts:

Latin America’s 33-Country Regulatory Patchwork Hinders Affordable Generic Drug Entry – DrugPatentWatch Report Omada Health Launches IPO Weeks After Hinge Health Goes Public in Digital Health Sector Online Pharmacy Market Growth Boosts Accessibility of Vitamins and Supplements While Raising Quality Concerns National Initiative Reduces Missed Radiation Therapy Appointments by 40 Percent

Author

GOAI